Which pharmaceutical marketing campaign is credited with destigmatizing depression and transforming it from a rarely discussed condition to a commonly treated medical disorder?

The pharmaceutical industry has seen numerous innovative marketing campaigns over the decades, transforming how medical products are promoted to healthcare professionals and patients. Some campaigns have revolutionized the industry and changed how we perceive certain conditions or treatments. Test your knowledge about a groundbreaking pharmaceutical marketing initiative that fundamentally altered an entire therapeutic category.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Eli Lilly's 'Depression: A Treatable Illness' campaign for Prozac (1987-1990)
Pfizer's 'Straight Talk About ED' campaign for Viagra (1998-2000)
Johnson & Johnson's 'Live Without Limits' campaign for Remicade (2002-2005)
GlaxoSmithKline's 'I Can Breathe' campaign for Advair (2001-2004)